Supplementary Table S4 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

Supplementary Table S4 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

<p>Supplementary Table S4. Mutations status of patients with disease progression on BTKis</p>

שמור ב:
מידע ביבליוגרפי
מחבר ראשי: Anfal Alsadhan (15907475) (author)
מחברים אחרים: Jonathan Chen (15907478) (author), Erika M. Gaglione (15032498) (author), Chingiz Underbayev (15907481) (author), Pamela L. Tuma (15907484) (author), Xin Tian (15907487) (author), Lita A. Freeman (15907490) (author), Sivasubramanian Baskar (15907493) (author), Pia Nierman (15907496) (author), Susan Soto (15907499) (author), Andy Itsara (15907502) (author), Inhye E. Ahn (15032501) (author), Clare Sun (14953020) (author), Elena Bibikova (15907505) (author), Tanja Nicole Hartmann (15907508) (author), Maissa Mhibik (15907511) (author), Adrian Wiestner (15907514) (author)
יצא לאור: 2025
נושאים:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Cell Signaling
Cell adhesion
Protein tyrosine kinases
Drug Resistance
Hematological Cancers
Leukemias
Lymphomas
Immunology
Immunomodulation
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
היה/י הראשונ/ה לכתוב הערה!
צריך להיות מחובר מראש

פריטים דומים